Skip to content

派珀桑德勒

US · PIPR #2212 按市值排名 上市于 1970
64.62 +0.05 +0.08%
实时 - 追踪5344个代码 - 心跳于17秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

增持
  • 最近一期(2026/Q3)披露持股的机构数量减少了3家。
  • 机构持股总比例上升了0.5个百分点。

机构持股

机构持股比例
93.31% +0.50pp
机构数量
488 -3
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。

持股人类型

Mutual Fund81.87%
Hedge Fund4.95%
Individual/Insider3.34%
Public Company2.66%
Government Pension Fund1.64%
Sovereign Wealth Fund1.33%
Private Company0.45%
Insurance Company0.25%
Family Office/Trust0.11%
Other3.39%

主要股东 截至 2026-06-30

BlackRock 16.44% · 11.05M 股
Vanguard Portfolio Management, LLC 7.72% · 5.19M 股
Vanguard Capital Management, LLC 5.25% · 3.53M 股
Invesco Ltd. 4.39% · 2.95M 股
State Street Global Advisors 4.35% · 2.92M 股
Geode Capital Management, LLC 2.59% · 1.74M 股
Dimensional Fund Advisors 2.12% · 1.42M 股
North Reef Capital Management LP 2.01% · 1.35M 股
Westwood Management Corp. 1.84% · 1.24M 股
Stephens Investment Management Group, LLC 1.71% · 1.15M 股

条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 42次买入 · 7次卖出

姓名职务持股比例
Jonathan Doyle Vice Chairman, Senior Managing Principal & Head of Financial Services Group 0.71%
James Baker MD and Global Co-Head of Investment Banking & Capital Markets 0.70%
Chad Abraham Chairperson & CEO 0.62%
Debbra Schoneman President & MD 0.38%
Jean-Paul Peltier MD & Global Group Head of Healthcare Investment Banking 0.22%
Brian Sterling Director 0.16%
Michael Dillahunt Global Co-Head of Investment Banking & Capital Markets 0.15%
Philip Soran Lead Independent Director 0.12%
John Geelan MD, General Counsel & Secretary 0.08%
Katherine Clune Chief Financial Officer 0.07%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-29 Philip Soran Lead Independent Director Other Acquisition +383 --
2026-09-29 Brian Sterling Director Other Acquisition +383 --
2026-09-29 Ann Gallo Director Other Acquisition +383 --
2026-09-21 Wendy Schoppert Director Other Acquisition +1,396 --
2026-09-21 Wendy Schoppert Director Initial Statement of Beneficial 0 --
2026-09-10 Philip Soran Lead Independent Director Other Acquisition +214 --
2026-09-10 Victoria Holt Independent Director Other Acquisition +79 --
2026-09-10 Brian Sterling Director Other Acquisition +33 --
2026-09-10 Scott Taylor Independent Director Other Acquisition +91 --
2026-09-10 Robbin Mitchell Independent Director Other Acquisition +42 --
2026-09-10 Ann Gallo Director Other Acquisition +22 --
2026-06-29 Philip Soran Lead Independent Director Other Acquisition +345 --
2026-06-29 Brian Sterling Director Other Acquisition +345 --
2026-06-29 Ann Gallo Director Other Acquisition +345 --
2026-06-11 Philip Soran Lead Independent Director Other Acquisition +206 --
2026-06-11 Victoria Holt Independent Director Other Acquisition +76 --
2026-06-11 Brian Sterling Director Other Acquisition +31 --
2026-06-11 Scott Taylor Independent Director Other Acquisition +87 --
2026-06-11 Robbin Mitchell Independent Director Other Acquisition +40 --
2026-06-11 Ann Gallo Director Other Acquisition +20 --

Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

派珀桑德勒 讨论区 0 条评论

发表评论